Cargando…
microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway
BACKGROUND: Extrahepatic Cholangiocarcinoma (EHCC) is one of the uncommon malignancies in the digestive system which is characterized by a poor prognosis. Aberrations of miRNAs have been shown involved in the progression of this disease. In this study, we evaluated the expression and effects of miR-...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477414/ https://www.ncbi.nlm.nih.gov/pubmed/26077733 http://dx.doi.org/10.1186/s12885-015-1359-x |
_version_ | 1782377755769307136 |
---|---|
author | Qiao, Pengfei Li, Guodong Bi, Wen Yang, Lianmeng Yao, Lei Wu, Dequan |
author_facet | Qiao, Pengfei Li, Guodong Bi, Wen Yang, Lianmeng Yao, Lei Wu, Dequan |
author_sort | Qiao, Pengfei |
collection | PubMed |
description | BACKGROUND: Extrahepatic Cholangiocarcinoma (EHCC) is one of the uncommon malignancies in the digestive system which is characterized by a poor prognosis. Aberrations of miRNAs have been shown involved in the progression of this disease. In this study, we evaluated the expression and effects of miR-34a on EHCC. METHODS: miR-34a expression levels were detected in EHCC tissues, adjacent non-tumor tissues, normal bile duct (NBD) specimens of patients and cholangiocarcinoma (CC) cell lines by quantitative real-time polymerase chain reaction (qRT-PCR). Relationships between miR-34a with clinical characteristics of EHCC patients were further analyzed. Computational search, functional luciferase assay and western blot were further used to demonstrate the downstream target of miR-34a in CC cells. Immunohistochemistry was carried on to identify the downstream target gene of miR-34a in EHCC patients. Cell morphology, invasion and migration assays were further applied to confirm the anti-carcinogenic effects of miR-34a through the downstream target. RESULTS: miR-34a expression was significantly decreased in human EHCC tissues and CC cell lines when compared with the adjacent non-tumor tissues and normal bile duct tissues. miR-34a was found correlated with the migration and invasion in EHCC patients. Smad4 was over-expressed in most of the EHCC patients and was further demonstrated as one of the downstream targets of miR-34a, which was involved in the progression of EHCC. Moreover, activation of miR-34a suppressed invasion and migration through TGF-beta/Smad4 signaling pathway by epithelial-mesenchymal transition (EMT) in vitro. CONCLUSIONS: Taken together, our results suggest that miR-34a inhibits invasion and migration by targeting Smad4 to suppress EMT through TGF- beta/Smad signaling pathway in human EHCC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1359-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4477414 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44774142015-06-24 microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway Qiao, Pengfei Li, Guodong Bi, Wen Yang, Lianmeng Yao, Lei Wu, Dequan BMC Cancer Research Article BACKGROUND: Extrahepatic Cholangiocarcinoma (EHCC) is one of the uncommon malignancies in the digestive system which is characterized by a poor prognosis. Aberrations of miRNAs have been shown involved in the progression of this disease. In this study, we evaluated the expression and effects of miR-34a on EHCC. METHODS: miR-34a expression levels were detected in EHCC tissues, adjacent non-tumor tissues, normal bile duct (NBD) specimens of patients and cholangiocarcinoma (CC) cell lines by quantitative real-time polymerase chain reaction (qRT-PCR). Relationships between miR-34a with clinical characteristics of EHCC patients were further analyzed. Computational search, functional luciferase assay and western blot were further used to demonstrate the downstream target of miR-34a in CC cells. Immunohistochemistry was carried on to identify the downstream target gene of miR-34a in EHCC patients. Cell morphology, invasion and migration assays were further applied to confirm the anti-carcinogenic effects of miR-34a through the downstream target. RESULTS: miR-34a expression was significantly decreased in human EHCC tissues and CC cell lines when compared with the adjacent non-tumor tissues and normal bile duct tissues. miR-34a was found correlated with the migration and invasion in EHCC patients. Smad4 was over-expressed in most of the EHCC patients and was further demonstrated as one of the downstream targets of miR-34a, which was involved in the progression of EHCC. Moreover, activation of miR-34a suppressed invasion and migration through TGF-beta/Smad4 signaling pathway by epithelial-mesenchymal transition (EMT) in vitro. CONCLUSIONS: Taken together, our results suggest that miR-34a inhibits invasion and migration by targeting Smad4 to suppress EMT through TGF- beta/Smad signaling pathway in human EHCC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1359-x) contains supplementary material, which is available to authorized users. BioMed Central 2015-06-16 /pmc/articles/PMC4477414/ /pubmed/26077733 http://dx.doi.org/10.1186/s12885-015-1359-x Text en © Qiao et al. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Qiao, Pengfei Li, Guodong Bi, Wen Yang, Lianmeng Yao, Lei Wu, Dequan microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway |
title | microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway |
title_full | microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway |
title_fullStr | microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway |
title_full_unstemmed | microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway |
title_short | microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway |
title_sort | microrna-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting smad4 through transforming growth factor-beta/smad pathway |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477414/ https://www.ncbi.nlm.nih.gov/pubmed/26077733 http://dx.doi.org/10.1186/s12885-015-1359-x |
work_keys_str_mv | AT qiaopengfei microrna34ainhibitsepithelialmesenchymaltransitioninhumancholangiocarcinomabytargetingsmad4throughtransforminggrowthfactorbetasmadpathway AT liguodong microrna34ainhibitsepithelialmesenchymaltransitioninhumancholangiocarcinomabytargetingsmad4throughtransforminggrowthfactorbetasmadpathway AT biwen microrna34ainhibitsepithelialmesenchymaltransitioninhumancholangiocarcinomabytargetingsmad4throughtransforminggrowthfactorbetasmadpathway AT yanglianmeng microrna34ainhibitsepithelialmesenchymaltransitioninhumancholangiocarcinomabytargetingsmad4throughtransforminggrowthfactorbetasmadpathway AT yaolei microrna34ainhibitsepithelialmesenchymaltransitioninhumancholangiocarcinomabytargetingsmad4throughtransforminggrowthfactorbetasmadpathway AT wudequan microrna34ainhibitsepithelialmesenchymaltransitioninhumancholangiocarcinomabytargetingsmad4throughtransforminggrowthfactorbetasmadpathway |